Astellas Venture & JIC Venture Growth in Tooth Regeneration Drug Development
02 Sep 2024
US$ 19.00
Astellas Venture Management, the US-based corporate venture arm of Japan’s Astellas Pharma Inc, has joined JIC Venture G...
Related Publications
5Y Capital has made a follow-on investment in the near Rmb600 m (US$86 m) series C funding round of Chengdu Zenitar ......
Coller Capital has closed its Coller International Partners IX (CIP IX), its largest ever global secondaries fund ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.